Business Wire

Cargill Puts Bold Innovation at Center of Effort to Decarbonize Shipping

15.1.2025 08:00:00 CET | Business Wire | Press release

Share

Continued investment in wind assisted propulsion, next-generation fuels and digital solutions key to moving the world’s goods more sustainably

Cargill is advancing a new era in sustainable shipping, putting innovation and collaboration at the core of its mission to move goods responsibly across the globe. Through wind-assisted propulsion technologies, dual-fuel methanol-powered vessels, and digital solutions, Cargill is setting the standard for helping the industry advance progress toward the International Maritime Organization’s (IMO) 2050 net-zero target. Combining technical expertise with a commitment to industry-wide partnerships, Cargill is helping to future-proof the maritime sector while enabling customers to meet their sustainability goals.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114753261/en/

“Decarbonizing shipping is a monumental task that requires courage, innovation, and collaboration,” said Jan Dieleman, president of Cargill’s Ocean Transportation business. “Our role extends beyond freight-shipping services; we aim to catalyze a shift across the industry toward sustainable practices. Through strategic investments in cutting-edge technology and robust partnerships, we are accelerating the journey to net-zero emissions in shipping.”

Innovating with Wind-Assisted Propulsion: The Pyxis Ocean and Beyond

Leading the charge in wind-assisted propulsion, the Pyxis Ocean—the first dry bulk vessel equipped with BAR Technologies’ WindWings®—completed its maiden voyage in 2023. WindWings are large, rigid sails that harness wind power to reduce fuel use and emissions.

In addition to WindWings, Cargill has expanded its wind-assisted technology program to include VentoFoil vertical suction sails on the NBA Magritte and rotor sails on the TR Lady. With these three vessels the company is experimenting and learning before scaling up technical, operational and commercial aspects. These technologies further utilize wind power to decrease fuel dependency and emissions, aligning with the IMO's target to have 5-10% of maritime energy from renewable sources by 2030.

Cargill believes that wind could make an important contribution to achieving decarbonization goals in the short, medium, and long term. Dieleman says that while the cost of fuels that could contribute to a zero-carbon future may remain high, developing, testing, and improving wind assisted propulsion technologies before these fuels are available could reduce reliance on them.

Transforming Fuels: Biofuels and Methanol-Powered Vessels

Alongside wind propulsion, Cargill is transforming fuel usage across its fleet. The company is pioneering biofuels made from renewable sources, such as fatty acid methyl esters (FAME), providing a drop-in fuel option to lower emissions without extensive engine modifications. In 2023, the company moved from trialing these fuels to frequent execution as it prepares to scale up. Nearly 172,000 metric tons of biofuel blends containing 63,000 metric tons of FAME was lifted in 2023. Cargill is also the first dry-bulk charterer to sign commercial agreements for dual-fuel methanol-powered ships, which are expected to be operational within the next two years. Methanol, a low-carbon alternative fuel, offers a scalable pathway to zero emissions. These methanol-powered vessels—the first of their kind in commercial service—highlight Cargill’s proactive approach in adopting sustainable fuel solutions to support both its own and its customers’ ambitious Scope 3 emissions reduction goals.

Harnessing Digital Solutions for Efficiency and Sustainability

Digital innovation is also central to Cargill ’s decarbonization efforts. Cargill is using advanced digital tools, including voyage optimization technologies, to create digital twins of its vessels. This enables optimal speed and route planning to reduce fuel consumption and emissions. Partnering with ZeroNorth, Cargill leverages these digital solutions to enhance operational efficiency and sustainability, reinforcing its commitment to data-driven progress toward net-zero.

Building a Sustainable Future Through Collaboration

Recognizing that decarbonizing the maritime industry requires a collaborative approach, Cargill partners across the sector to drive meaningful progress. As a founding member of the Maersk Mc-Kinney Moller Center for Zero Carbon Shipping, Cargill works with industry leaders to test and promote alternative fuels, including ammonia and methanol. Cargill is also a key player in the Sea Cargo Charter, a coalition dedicated to reducing shipping’s climate impact through transparency and shared decarbonization frameworks.

“As we continue this journey, we’re focused on solutions that don’t just improve our own operations but drive change across the industry,” added Dieleman. “Our vision is a shipping sector that delivers the goods the world needs while protecting our planet’s future. We’re proud to be part of this transformation and are committed to building a more sustainable future for global shipping.”

For additional information about Cargill’s efforts to decarbonize shipping, visit https://www.cargill.com/transportation/ocean-transportation-sustainability.

About Cargill

Cargill is committed to providing food, ingredients, agricultural solutions, and industrial products to nourish the world in a safe, responsible, and sustainable way. Sitting at the heart of the supply chain, we partner with farmers and customers to source, make and deliver products that are vital for living.

Our 160,000 team members innovate with purpose, providing customers with life’s essentials so businesses can grow, communities prosper, and consumers live well. With 159 years of experience as a family company, we look ahead while remaining true to our values. We put people first. We reach higher. We do the right thing—today and for generations to come. For more information, visit Cargill.com and our News Center.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250114753261/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye